TORONTO, June 22, 2023 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today announced that, at the request of the Company's board of directors and following the recommendation of the audit committee, the Company's board of directors have accepted the resignation of KPMG LLP as the auditor of the Company effective June 5, 2023 and approved the appointment of MNP LLP as successor auditor effective June 5, 2023.
Read more at newswire.caMediPharm Labs Announces Change of Auditor
Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.
